You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Pharma Investment Still Strong in U.K. R&D Despite Brexit

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 773 Words

GALWAY, IRELAND--July 11, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Investment in the U.K.'s pharmaceutical sector remains strong despite the future uncertainty of Brexit.

Within this article: Details investment in U.K. R&D, trends, potential impact of Brexit on healthcare, warnings from leading pharma giants

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00